ReviewJournal of hand surgery global online2026
Amyloidosis and Carpal Tunnel Syndrome: An Update on Diagnostic and Management Considerations.
Review in Journal of hand surgery global online, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the past decade, hand and upper-extremity surgeons have become increasingly aware of the relationship between carpal tunnel syndrome and cardiac amyloidosis. Recent advances in medical management of cardiac amyloidosis in the form of disease-modifying therapies that improve survival have aided decreasing morbidity and in some cases, hand surgeons can detect evidence of amyloid deposition prior to clinical manifestations of cardiac disease. Despite improvements in biopsy techniques and analysis, there remain a number of controversies related to this condition that directly impact upper-extremity surgeons. At present, the number needed to screen for biopsy procedures during carpal tunnel release remains poorly defined relative to routine cancer screening protocols and there are a paucity of prior investigations assessing the costs associated with biopsy during carpal tunnel release. This narrative review aims to provide an update on diagnostic and management considerations for hand surgeons evaluating patients with carpal tunnel syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.